GRI

1st Advanced Regenerative Medicine and Advanced Biopharmaceutical Deliberation Committee held

News Healthcare & Pharma General Updates
Date: 24th Jan, 2025 Source: Ministry of Health and Welfare (MOHW) Country: South Korea Original Source

Brief

"On January 23, 2025, the Ministry of Health and Welfare (MOHW) hosted the 1st Advanced Regenerative Medicine and Advanced Biopharmaceutical Deliberation Committee. The committee reviewed two clinical research plans, with one deemed suitable for approval and the other rejected. The approved study aims to investigate the efficacy of a combined treatment involving mFOLFIRINOX and autologous cytokine-induced killer cells for patients with advanced pancreatic cancer."

This content is restricted.

Highlights content goes here...

This content is restricted.

Ministry of Health and Welfare (MOHW)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Thousands of sick and disabled people to get life-changing support into work
Date: 4th Sep, 2025 Source: Department for Work and Pensions Country: United Kingdom
News Employment & labor General Updates
Financial authorities, MG Insurance Insurance Agreement is transferred to non -reporting (bridge insurance company)
Date: 3rd Sep, 2025 Source: Financial Services Commission Country: South Korea
News Corporate Finance & M&A General Updates
BYD exports Thai -made electric vehicles to Europe
Date: 3rd Sep, 2025 Source: Ministry of Trade (Ticaret Bakanlığı) Country: Turkey
News Consumer protection General Updates

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales